We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

230 hedge funds and large institutions have $1.96B invested in Arena Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 83 increasing their positions, 58 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 25

43% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 58

7% more funds holding

Funds holding: 215 → 230 (+15)

21% less capital invested

Capital invested by funds: $2.47B → $1.96B (-$506M)

28% less call options, than puts

Call options by funds: $12M | Put options by funds: $16.7M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
230
Holders Change
+15
Holders Change %
+6.98%
% of All Funds
5.04%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
40
Increased
83
Reduced
58
Closed
25
Calls
$12M
Puts
$16.7M
Net Calls
-$4.73M
Net Calls Change
-$7.79M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$24.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$16.7M
3
State Street
State Street
Massachusetts
+$14.8M
4
Marshall Wace
Marshall Wace
United Kingdom
+$12.5M
5
APG Asset Management
APG Asset Management
Netherlands
+$12.5M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$46.5M
2
PA
Perceptive Advisors
New York
-$24M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$11.2M
4
Primecap Management
Primecap Management
California
-$8.95M
5
EMG
ETF Managers Group
New Jersey
-$8.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
101
Erste Asset Management
Austria
$1.21M – – –
AAM
102
Advisors Asset Management
Colorado
$1.2M +$340K +6,042 +30%
HSA
103
Hussman Strategic Advisors
Maryland
$1.18M +$1.45M +25,750 New
State Board of Administration of Florida Retirement System
104
State Board of Administration of Florida Retirement System
Florida
$1.15M – – –
AL
105
AJO LP
Pennsylvania
$1.13M -$2.01M -35,735 -59%
WG
106
Winton Group
United Kingdom
$1.11M +$480K +8,542 +54%
LCG
107
Lisanti Capital Growth
New York
$1.11M +$1.36M +24,235 New
CIP
108
Convergence Investment Partners
Florida
$1.08M +$1.11M +19,717 +516%
BG
109
Bellevue Group
Switzerland
$1.08M -$1.32M -23,400 -50%
SO
110
STRS Ohio
Ohio
$1.07M +$39.3K +700 +3%
PPA
111
Parametric Portfolio Associates
Washington
$1.07M -$908K -16,159 -41%
ARTA
112
A.R.T. Advisors
New York
$1.05M +$1.29M +22,931 New
MIM
113
MetLife Investment Management
New Jersey
$1.03M – – –
T. Rowe Price Associates
114
T. Rowe Price Associates
Maryland
$1.02M +$13.2K +234 +1%
BC
115
Birchview Capital
Vermont
$1.01M – – –
BPM
116
Bowling Portfolio Management
Ohio
$980K +$1.2M +21,406 New
Ohio Public Employees Retirement System (OPERS)
117
Ohio Public Employees Retirement System (OPERS)
Ohio
$908K +$421K +7,489 +61%
TRSOTSOK
118
Teachers Retirement System of the State of Kentucky
Kentucky
$886K – – –
ProShare Advisors
119
ProShare Advisors
Maryland
$878K -$30.7K -547 -3%
Ameriprise
120
Ameriprise
Minnesota
$845K -$1.13M -20,064 -52%
HighTower Advisors
121
HighTower Advisors
Illinois
$825K +$208K +3,693 +26%
Jennison Associates
122
Jennison Associates
New York
$816K +$1M +17,827 New
IBT
123
International Biotechnology Trust
United Kingdom
$755K – – –
ACM
124
Asymmetry Capital Management
California
$745K +$915K +16,272 New
MLICM
125
Metropolitan Life Insurance Company (MetLife)
New York
$733K +$10.4K +185 +1%
3 4
5
6 7

ARNA Hedge Fund Activity: Q3 2019 in Review

230 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2019, worth a combined $1.96B — down 21% from $2.47B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new ARNA positions and 25 closed out — a net gain of 15 holders — while 83 added to existing stakes and 58 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $24.9M. The largest seller was Fidelity Investments, cutting an estimated $46.5M.

  • 230 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2019, up from 215 in Q2 2019.
  • Funds reported $1.96B of Arena Pharmaceuticals Inc stock for Q3 2019, down 21% quarter-over-quarter.
  • 40 funds opened new Arena Pharmaceuticals Inc positions in Q3 2019 and 25 closed out, a net change of +15 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2019 was PFM Health Sciences, an estimated $24.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2019 was Fidelity Investments, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2019.